Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
International Journal of MS Care|January 17, 2022
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data SourcesLotte Geys, Tina Parciak, Ashkan Pirmani, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Neurology|August 4, 2017
Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophyJeroen J J van Eijk, Harry R Dalton, Paolo Ripellino, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Neurology|January 2, 2024
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MSAlessandro Cagol, Pascal Benkert, Lester Melie-Garcia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2019
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experienceChiara Zecca, Francesca Bovis, Giovanni Novi, et al.
JAMA Neurology|May 16, 2022
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple SclerosisAlessandro Cagol, Sabine Schaedelin, Muhamed Barakovic, et al.
Annals of Neurology|October 16, 2024
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple SclerosisPascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, et al.
JAMA Neurology|August 3, 2026
Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple SclerosisMaximilian Einsiedler, Sofia Sandgren, Sabine Schaedelin, et al.
Pageof 17